Allergan's dubious drug deal

Air Date: Sep 12, 2017 7:53 PM ET

Allergan's dubious drug deal6:50

Pharmaceutical company Allergan says it will transfer the patent to eye medication Restasis, to the Saint Regis Mohawk Tribe in a deal that Wall Street analysts call 'innovative' and tax efficient. But Bloomberg journalist Joe Nocera says it's nothing more than a "sleazy" way to block cheaper generic drugs

Markets

TSX COMPOSITE
 
Nov 22, 2017 12:00 AM ET Nov 22, 2017 12:00 AM ET Nov 22, 2017 12:00 AM ET Nov 22, 2017 12:00 AM ET Nov 22, 2017 12:00 AM ET
Index Last Trade Change
TSX COMPOSITE 16076.65 72.25
DOW 23590.83 160.50
NASDAQ 6862.48 71.77
SP 500 2599.03 16.89
>TSX-VENTURE 794.55 0.42

The data on this site is informational only and may be delayed; it is not intended as trading or investment advice and you should not rely on it as such.

Stay Connected with CBC News